A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer
Clinical trial NCT04946864 · SUSPENDED
Trial details
- NCT number
- NCT04946864
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-13
- Primary completion
- 2024-08-12
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.